Two clinical trials of gold nanocrystals at University of Texas Southwestern Medical Center resulted in “significantly reversed deficits of metabolites linked to energy activity in the brain and resulted in functional improvements” in patients with multiple sclerosis (MS) and Parkinson’s disease, the medical center said in a Feb. 13 news announcement. While these trials focused…
The U.S. Food & Drug Administration (FDA) has given 510(k) clearance to Pixyl.Neuro, brain MRI analysis software that’s powered by artificial intelligence (AI). In a Nov. 20 news announcement, Pixyl, a French medtech company specializing in AI-powered MRI solutions to improve patient care, said Pixyl.Neuro “automatically analyzes brain MRI images to support rapid detection, early…
A new clinical trial found that people living with multiple sclerosis (MS) reported less fatigue while following a low-fat diet. The study was published in the Multiple Sclerosis Journal, November 2023 (volume 29, issue 13). Thirty-nine people living with MS participated in the 16-week randomized controlled trial: 20 in the active group and 19 in…
GA Depot offers a once-monthly administration that could be more convenient for patients.
Researchers also found multiple sclerosis to be more common in certain regions.
New drug has shown in studies to decrease multiple sclerosis relapse rates.
Multiple sclerosis impacts clients physically and cognitively. Its lack of predictability can make successful interventions difficult to choose.
Small clinical trial suggests adding antibiotic to interferon treatment could help multiple sclerosis patients.
Manufacturer B-TEMIA says exoskeleton has been used by consumers with incomplete spinal cord injuries, Parkinson’s disease and multiple sclerosis.
Targeted therapy strategy could reduce patients’ exposure to side effects.